HER2 is thought to exert its activity through activation of several tumorigenic intracellular pathways, such as PI3K/Akt/mTOR and RAS/RAF/MEK/ERK1/2 to enhance tumor cell growth, proliferation and invasion 22. This evidence concerns the gene AKT1 and neoplasm.